MUC16 and pachyonychia congenita: In our previous study, we showed de novo expression of MUC16 in the high-grade preneoplastic lesion, primary as well as metastatic PC with metastatic tumors having stronger MUC16 expression compared to the primary tumors from the same patient [33].